Publication | Closed Access
BCL-2 system analysis identifies high-risk colorectal cancer patients
52
Citations
19
References
2016
Year
DR_MOMP delivers a system-based biomarker with significant potential as a prognostic tool for stage III CRC that significantly improves established histopathological risk factors.
| Year | Citations | |
|---|---|---|
Page 1
Page 1